Surveillance of Candida spp Bloodstream Infections: Epidemiological Trends and Risk Factors of Death in Two Mexican Tertiary Care Hospitals
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Surveillance of Candida spp Bloodstream Infections: Epidemiological Trends and Risk Factors of Death in Two Mexican Tertiary Care Hospitals
Authors
Keywords
Antifungals, Candida albicans, Death rates, Candida, Bloodstream infections, Epidemiology, Liver diseases, Nosocomial infections
Journal
PLoS One
Volume 9, Issue 5, Pages e97325
Publisher
Public Library of Science (PLoS)
Online
2014-05-16
DOI
10.1371/journal.pone.0097325
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey
- (2013) Marcio Nucci et al. PLoS One
- Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients
- (2011) M. Mikulska et al. INFECTION
- Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
- (2010) Olivier Lortholary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology of Opportunistic Fungal Infections in Latin America
- (2010) Marcio Nucci et al. CLINICAL INFECTIOUS DISEASES
- Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion
- (2010) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Contamination of intravenous fluids: A continuing cause of hospital bacteremia
- (2009) Alejandro E. Macias et al. AMERICAN JOURNAL OF INFECTION CONTROL
- The Effect of Time to Antifungal Therapy on Mortality in Candidemia Associated Septic Shock
- (2009) Gourang P Patel et al. AMERICAN JOURNAL OF THERAPEUTICS
- Blood Stream Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Reemergence of Gram-Negative Rods and Increasing Antibiotic Resistance
- (2009) Malgorzata Mikulska et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry
- (2009) David L. Horn et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter‐Related Infection: 2009 Update by the Infectious Diseases Society of America
- (2009) Leonard A. Mermel et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006)
- (2009) Olivier Leroy et al. CRITICAL CARE MEDICINE
- Factors Associated with Candidemia Caused by Non‐albicans CandidaSpecies VersusCandida albicansin the Intensive Care Unit
- (2008) Jennifer K. Chow et al. CLINICAL INFECTIOUS DISEASES
- Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit
- (2008) S. Faiz et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Trends in Species Distribution and Susceptibility of Bloodstream Isolates of Candida Collected in Monterrey, Mexico, to Seven Antifungal Agents: Results of a 3-Year (2004 to 2007) Surveillance Study
- (2008) G. M. Gonzalez et al. JOURNAL OF CLINICAL MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started